Andreas Puschmann
61 – 70 of 117
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Heterozygous PINK1 p.G411S mutation increases risk for Parkinson's disease (PD)
2016) 20th International Congress of Parkinson's Disease and Movement Disorders In Movement Disorders 31(Suppl. S2). p.282-282(
- Contribution to journal › Published meeting abstract
-
Mark
18F-AV1451 pet detects tau pathology in mapt mutation carriers and correlates strongly with immunohistochemistry of tau aggregates
2016) Alzheimer’s Association International Conference 2016 In Alzheimer's and Dementia 12(7 Suppl). p.723-724(
- Contribution to journal › Published meeting abstract
- 2015
-
Mark
Role for the microtubule-associated protein tau variant p.A152T in risk of α-synucleinopathies.
(
- Contribution to journal › Article
-
Mark
CHCHD2 and Parkinson's disease
(
- Contribution to journal › Letter
-
Mark
Clinical Correlations With Lewy Body Pathology in LRRK2-Related Parkinson Disease.
(
- Contribution to journal › Article
-
Mark
DNAJC13 p.Asn855Ser mutation screening in Parkinson's disease and pathologically confirmed Lewy body disease patients.
(
- Contribution to journal › Article
-
Mark
Clinically meaningful parameters of progression and long-term outcome of Parkinson disease: An international consensus statement.
(
- Contribution to journal › Article
-
Mark
Mitochondrial targeting sequence variants of the CHCHD2 gene are a risk for Lewy body disorders.
2015) In Neurology(
- Contribution to journal › Article
-
Mark
Improving the likelihood of neurology patients being examined using patient feedback
(
- Contribution to journal › Article
-
Mark
The TOS2 study: An international multi-centre audit assessing the standard of neurological examination
(
- Contribution to journal › Published meeting abstract